UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database

ESMO open, 2021-06, Vol.6 (3), p.100150-100150, Article 100150

2021

Volltextzugriff (PDF)

Impact of breast cancer molecular subtypes on the occurrence, kinetics and prognosis of central nervous system metastases in a large multicenter cohort

Annals of oncology, 2018-10, Vol.29, p.viii115-viii115

2018

Volltextzugriff (PDF)

EP1161 Exome analysis of vulvar and vaginal tumors reveals an antigen processing and presentation deficiency

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A602-A603

2019

Volltextzugriff (PDF)

43P Single-arm phase II of desynchronized irinotecan plus bevacizumab, oxaliplatin, 5-fluorouracil, and folinic acid (bFOLFIRINOX-3) administration in chemorefractory metastatic colorectal cancer patients

Annals of oncology, 2024-06, Vol.35, p.S21-S22

2024

Volltextzugriff (PDF)

433P Durvalumab and tremelimumab in combination with FOLFOX in patients with previously untreated RAS-mutated metastatic colorectal cancer: First results of efficacy at one year for phase II MEDITREME trial

Annals of oncology, 2021-09, Vol.32, p.S551-S551

2021

Volltextzugriff (PDF)

774P Initial management and long-term outcome of ovarian clear cell carcinoma (OCCC) in the French multicentre ESME database

Annals of oncology, 2024-09, Vol.35, p.S583-S584

2024

Volltextzugriff (PDF)

660P Atezolizumab plus UCPvax telomerase CD4 TH1-inducer cancer vaccine for the treatment of chemorefractory HPV+ cancers: Safety and efficacy results of the VolATIL phase II study

Annals of oncology, 2024-09, Vol.35, p.S520-S520

2024

Volltextzugriff (PDF)

54P Phase I dose-escalation study of trifluridine/tipiracil plus XB2001 and bevacizumab in chemorefractory advanced colorectal cancer: The TASKIN study

Annals of oncology, 2024-06, Vol.35, p.S26-S26

2024

Volltextzugriff (PDF)

EP1.01-25 An Interactive Interface for Prediction of Anti-PD-1 Efficacy in Lung Cancer Patients

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S921-S921

2019

Volltextzugriff (PDF)

Evaluation of the safety and the tolerability of durvalumab plus tremelimumab combined with FOLFOX in metastatic colorectal cancer (MEDITREME)

Annals of oncology, 2018-12, Vol.29, p.x31-x31

2018

Volltextzugriff (PDF)

85PEvaluation of the safety and the tolerability of durvalumab plus tremelimumab combined with FOLFOX in metastatic colorectal cancer (MEDITREME)

Annals of oncology, 2018-12, Vol.29 (suppl_10)

2018

Volltextzugriff (PDF)

P2.01-97 Angiotensin-Converting Enzyme Inhibitor Is Associated with Decreased Survival in NSCLC Patients Treated with PD-1 Checkpoint Blockers

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S678-S679

2019

Volltextzugriff (PDF)

KS01.6.A UCPVAX-GLIO: A PHASE II TRIAL EVALUATING THE IMMUNOGENICITY AND EFFICACY OF AN ANTI-TELOMERASE VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GBM

Neuro-oncology (Charlottesville, Va.), 2023-09, Vol.25 (Supplement_2), p.ii3-ii4

2023

Volltextzugriff (PDF)

102P Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases: Characteristics and validation of prognostic models in a large real-life database

Annals of oncology, 2021-05, Vol.32, p.S67

2021

Volltextzugriff (PDF)

Tratamiento del cáncer de mama infiltrante localizado: nuevos desafíos

EMC - Ginecología-Obstetricia, 2021-10, Vol.57 (4), p.1-20

2021

Volltextzugriff (PDF)

P1.01-116 Early Immune-Related Adverse Events Under PD-1/PD-L1 Inhibitors Predict Better Progression-Free Survival in NSCLC

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S407-S407

2019

Volltextzugriff (PDF)

1884P - Metastatic cancer whole-exome sequencing in daily practice

Annals of oncology, 2019-10, Vol.30, p.v765-v765

2019

Volltextzugriff (PDF)

1884PMetastatic cancer whole-exome sequencing in daily practice

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Metastatic cancer whole-exome sequencing in daily practice

Annals of oncology, 2019-10, Vol.30, p.v765

2019

Volltextzugriff (PDF)

351PImpact of breast cancer molecular subtypes on the occurrence, kinetics and prognosis of central nervous system metastases in a large multicenter cohort

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

An Interactive Interface for Prediction of Anti-PD-1 Efficacy in Lung Cancer Patients: EP1.01-25

Journal of thoracic oncology, 2019-10, Vol.14 (10 Suppl), p.S921-S921

2019

Volltextzugriff (PDF)

EXOME ANALYSIS OF VULVAR AND VAGINAL TUMORS REVEALS AN ANTIGEN PROCESSING AND PRESENTATION DEFICIENCY: EP1161

International journal of gynecological cancer, 2019-11, Vol.29 ESGO Annual Meeting Abstracts, p.A602-A603

2019

Volltextzugriff (PDF)

L’ immunoediting enfin prouvé chez l’homme: La génétique au secours de l’immunothérapie

M.S. Médecine sciences, 2019-08, Vol.35 (8-9), p.629-631

2019

Volltextzugriff (PDF)

Immunoediting eventually proven in humans. Genetics to assist immunotherapy

M.S. Médecine sciences, 2019-08, Vol.35 (8-9), p.629

2019

Volltextzugriff (PDF)

Regulation of Anguillicola crassus (Nematoda) infrapopulations in their definitive host, the European eel, Anguilla anguilla

Parasitology, 2008-12, Vol.135 (14), p.1707-1716

2008

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(35)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases in a large real-life database

Impact of breast cancer molecular subtypes on the occurrence, kinetics and prognosis of central nervous system metastases in a large multicenter cohort

EP1161 Exome analysis of vulvar and vaginal tumors reveals an antigen processing and presentation deficiency

43P Single-arm phase II of desynchronized irinotecan plus bevacizumab, oxaliplatin, 5-fluorouracil, and folinic acid (bFOLFIRINOX-3) administration in chemorefractory metastatic colorectal cancer patients

433P Durvalumab and tremelimumab in combination with FOLFOX in patients with previously untreated RAS-mutated metastatic colorectal cancer: First results of efficacy at one year for phase II MEDITREME trial

774P Initial management and long-term outcome of ovarian clear cell carcinoma (OCCC) in the French multicentre ESME database

660P Atezolizumab plus UCPvax telomerase CD4 TH1-inducer cancer vaccine for the treatment of chemorefractory HPV+ cancers: Safety and efficacy results of the VolATIL phase II study

54P Phase I dose-escalation study of trifluridine/tipiracil plus XB2001 and bevacizumab in chemorefractory advanced colorectal cancer: The TASKIN study

EP1.01-25 An Interactive Interface for Prediction of Anti-PD-1 Efficacy in Lung Cancer Patients

Evaluation of the safety and the tolerability of durvalumab plus tremelimumab combined with FOLFOX in metastatic colorectal cancer (MEDITREME)

85PEvaluation of the safety and the tolerability of durvalumab plus tremelimumab combined with FOLFOX in metastatic colorectal cancer (MEDITREME)

P2.01-97 Angiotensin-Converting Enzyme Inhibitor Is Associated with Decreased Survival in NSCLC Patients Treated with PD-1 Checkpoint Blockers

KS01.6.A UCPVAX-GLIO: A PHASE II TRIAL EVALUATING THE IMMUNOGENICITY AND EFFICACY OF AN ANTI-TELOMERASE VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GBM

102P Breast cancer patients treated with intrathecal therapy for leptomeningeal metastases: Characteristics and validation of prognostic models in a large real-life database

Tratamiento del cáncer de mama infiltrante localizado: nuevos desafíos

P1.01-116 Early Immune-Related Adverse Events Under PD-1/PD-L1 Inhibitors Predict Better Progression-Free Survival in NSCLC

1884P - Metastatic cancer whole-exome sequencing in daily practice

1884PMetastatic cancer whole-exome sequencing in daily practice

Metastatic cancer whole-exome sequencing in daily practice

351PImpact of breast cancer molecular subtypes on the occurrence, kinetics and prognosis of central nervous system metastases in a large multicenter cohort

An Interactive Interface for Prediction of Anti-PD-1 Efficacy in Lung Cancer Patients: EP1.01-25

EXOME ANALYSIS OF VULVAR AND VAGINAL TUMORS REVEALS AN ANTIGEN PROCESSING AND PRESENTATION DEFICIENCY: EP1161

L’ immunoediting enfin prouvé chez l’homme: La génétique au secours de l’immunothérapie

Immunoediting eventually proven in humans. Genetics to assist immunotherapy

Regulation of Anguillicola crassus (Nematoda) infrapopulations in their definitive host, the European eel, Anguilla anguilla

Suchergebnisse filtern